FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68 Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting. The designation recognizes the ...

Medvue Concorde medical imaging clinic has become the first in Quebec to acquire the Siemens MAGNETOM Flow.Elite, a next-generation magnetic resonance imaging (MRI) system that integrates artificial ...

The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients.Telix has positively engaged with the FDA on a New ...

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from ...

FEW days ago, a senior pastor of mine called and spoke fata-fata, as they say, about the state of our hospitals. His preambles were something else; it went something like this: Pastor Bolawole, I know ...

Altamuskin man Shane McCarney is living with stage four metastatic prostate cancer after years supporting cancer patients as a clinical psychologist.

[by Yu, Suin] “We expect revenue to more than double year-over-year in 2026 and aim to reach the break-even point (BEP) in ...

Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that ...

Although mpMRI can improve targeting of clinically significant prostate cancer, its performance depends in part on obtaining ...

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.

The EURO-PROBE dataset provides manually created segmentations of the prostate and intraprostatic urethra on axial T2-weighted MRI volumes, complementing the existing LUND-PROBE (LUND Prostate ...

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...